← Eichor
Study identifier: NCT04642807 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Management of Type 1 Supracondylar Humeral Fractures

Condition: Elbow Fracture · Trauma  ·  Sponsor: University of British Columbia

PhaseNA
Planned participants52
Who can joinAll sexes, 3 Years to 8 Years
Healthy volunteersYes

About this study

This study compares the clinical outcomes of treating pediatric Type 1 supracondylar fracture with a long arm soft cast and no clinical or radiographic follow-up versus the standard treatment in a long arm cast with clinical follow-up. This is the first multicenter randomized control trial looking at the clinical effectiveness, safety and parental satisfaction of managing inherently stable Type I supracondylar fractures without clinical or radiological follow-up. If found to be safe; children can be managed effectively without in-person follow-up, freeing clinic appointments to children on the waiting list and in these COVID times avoiding unnecessary contacts.

This description comes directly from the study's public registry record.

Talk to the study team

Harpreet Chhina, MSc  ·  604-875-2000  ·  hchhina@cw.bc.ca

Anthony Cooper, FRCSC  ·  604-875-2000  ·  externalfixators@cw.bc.ca

Always discuss trial participation with your own doctor first.

Locations (2)

Queensland Children's Hospital, 501 Stanley Street,South Brisbane, AustraliaRecruiting
BC Children's HospitalVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04642807